CARBOSILANE DENDRIMERS AND THE USE THEREOF AS ANTIVIRAL AGENTS

Patent number:

US2013059818

Comunidad de Madrid.svg
No items found.

Highly branched macromolecules synthesized from a polyfunctional core, preferably silicon, or polyphenolic, with a carbosilane structure at its periphery functionalized with groups, preferably anionic, giving to the macromolecule a net negative charge. Furthermore, the invention relates to the procedures for their synthesis and their uses as antiviral agents, antibacterial and antifungal agents.

Countries:
Spain
Regions:
Community of Madrid
Centers:
UNIVERSIDAD DE ALCALA
Other entities:
Sectors:
Health
Subsectors:
Pharmaceuticals, Macromolecular chemistry, polymers
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

The anti-inflammatory properties of these dendrimers are additional advantages with respect to other dendrimers with antiviral, antibacterial or antipyretic activity. In addition to the prophylactic application, they have therapeutic effect especially in sexually transmitted diseases, by preventing the infection of cells not yet infected. Their preparation as pharmaceutical formula can be very varied, being possible any solid composition (tablets, pills, capsules, granules, etc.) or liquid (gels, solutions, suspensions or emulsions). For oral, nasal, topical or parenteral administration, preferably the administration will be topical. These dendrimers by themselves have biological activity as antiviral agents. They have in vitro activity against a variety of viruses

Comments

Other related patents

Health
Chemicals

MAGNETIC NANOPARTICLES FOR USE IN THE TREATMENT OF TUMORS

Countries
Spain
Italy
Know more
Health

Use of aloe oral for hair improvement

Countries
Spain
Know more
Health

COLLECTIVE AIR DISINFECTION SYSTEM, EQUIPMENT AND PROCEDURE, AND DEVICE FOR THE INDIVIDUAL USE OF DISINFECTED AIR

Countries
Spain
Know more
Get back to patents directory